ReviewAnnals of hematology2025
Alemtuzumab for haematological malignancies.
Ning An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewAnnals of hematology2025
Ning An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.